Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06PDT
|
|||
| Former ID |
DIB004630
|
|||
| Drug Name |
TARP peptide-pulsed autologous dendritic cell vaccine
|
|||
| Synonyms |
TARP peptide-pulsed autologous dendritic cell vaccine (prostate cancer)
Click to Show/Hide
|
|||
| Indication | Prostate cancer [ICD-11: 2C82.0; ICD-10: C61; ICD-9: 185] | Phase 1 | [1] | |
| Company |
National Cancer Institute
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A Pilot Study of Vaccination with Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer. National Cancer Institute. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.